nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP19A1—prostate cancer	0.229	0.68	CbGaD
Anastrozole—CYP3A4—prostate cancer	0.107	0.32	CbGaD
Anastrozole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0361	0.0971	CbGbCtD
Anastrozole—CYP2C9—Bicalutamide—prostate cancer	0.0326	0.0877	CbGbCtD
Anastrozole—CYP2C9—Nilutamide—prostate cancer	0.0326	0.0877	CbGbCtD
Anastrozole—CYP1A2—Flutamide—prostate cancer	0.03	0.0807	CbGbCtD
Anastrozole—CYP1A2—Estrone—prostate cancer	0.0217	0.0583	CbGbCtD
Anastrozole—CYP2C9—Estrone—prostate cancer	0.0196	0.0525	CbGbCtD
Anastrozole—CYP3A4—Bicalutamide—prostate cancer	0.019	0.051	CbGbCtD
Anastrozole—CYP3A4—Estramustine—prostate cancer	0.0176	0.0474	CbGbCtD
Anastrozole—CYP3A4—Flutamide—prostate cancer	0.0157	0.0423	CbGbCtD
Anastrozole—CYP3A4—Abiraterone—prostate cancer	0.0157	0.0423	CbGbCtD
Anastrozole—CYP2C9—Capecitabine—prostate cancer	0.0148	0.0398	CbGbCtD
Anastrozole—CYP1A2—Conjugated Estrogens—prostate cancer	0.0142	0.0382	CbGbCtD
Anastrozole—CYP1A2—Estradiol—prostate cancer	0.0125	0.0335	CbGbCtD
Anastrozole—CYP3A4—Cabazitaxel—prostate cancer	0.0116	0.0313	CbGbCtD
Anastrozole—CYP3A4—Estrone—prostate cancer	0.0114	0.0306	CbGbCtD
Anastrozole—CYP2C9—Estradiol—prostate cancer	0.0112	0.0302	CbGbCtD
Anastrozole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0101	0.0272	CbGbCtD
Anastrozole—CYP1A2—Etoposide—prostate cancer	0.00814	0.0219	CbGbCtD
Anastrozole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00744	0.02	CbGbCtD
Anastrozole—CYP3A4—Mitoxantrone—prostate cancer	0.00676	0.0182	CbGbCtD
Anastrozole—CYP3A4—Estradiol—prostate cancer	0.00653	0.0175	CbGbCtD
Anastrozole—CYP3A4—Prednisone—prostate cancer	0.00562	0.0151	CbGbCtD
Anastrozole—CYP3A4—Etoposide—prostate cancer	0.00426	0.0115	CbGbCtD
Anastrozole—CYP19A1—semen—prostate cancer	0.00417	0.346	CbGeAlD
Anastrozole—CYP3A4—Docetaxel—prostate cancer	0.0039	0.0105	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—prostate cancer	0.00291	0.00782	CbGbCtD
Anastrozole—CYP1A2—urine—prostate cancer	0.00195	0.162	CbGeAlD
Anastrozole—CYP2C9—urine—prostate cancer	0.00185	0.154	CbGeAlD
Anastrozole—CYP3A4—urine—prostate cancer	0.00141	0.117	CbGeAlD
Anastrozole—CYP19A1—prostate gland—prostate cancer	0.00104	0.0868	CbGeAlD
Anastrozole—CYP1A2—renal system—prostate cancer	0.000477	0.0396	CbGeAlD
Anastrozole—CYP19A1—testis—prostate cancer	0.00046	0.0382	CbGeAlD
Anastrozole—CYP3A4—renal system—prostate cancer	0.000345	0.0287	CbGeAlD
Anastrozole—CYP19A1—lymph node—prostate cancer	0.000334	0.0277	CbGeAlD
Anastrozole—Confusional state—Docetaxel—prostate cancer	3.39e-05	0.000176	CcSEcCtD
Anastrozole—Anxiety—Capecitabine—prostate cancer	3.39e-05	0.000176	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—prostate cancer	3.36e-05	0.000175	CcSEcCtD
Anastrozole—Anaphylactic shock—Docetaxel—prostate cancer	3.36e-05	0.000175	CcSEcCtD
Anastrozole—Oedema—Docetaxel—prostate cancer	3.36e-05	0.000175	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—prostate cancer	3.36e-05	0.000175	CcSEcCtD
Anastrozole—Discomfort—Capecitabine—prostate cancer	3.36e-05	0.000175	CcSEcCtD
Anastrozole—Infection—Docetaxel—prostate cancer	3.34e-05	0.000174	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—prostate cancer	3.34e-05	0.000174	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—prostate cancer	3.34e-05	0.000174	CcSEcCtD
Anastrozole—Feeling abnormal—Etoposide—prostate cancer	3.34e-05	0.000174	CcSEcCtD
Anastrozole—Diarrhoea—Mitoxantrone—prostate cancer	3.33e-05	0.000173	CcSEcCtD
Anastrozole—Dry mouth—Capecitabine—prostate cancer	3.32e-05	0.000173	CcSEcCtD
Anastrozole—Vomiting—Estradiol—prostate cancer	3.32e-05	0.000173	CcSEcCtD
Anastrozole—Gastrointestinal pain—Etoposide—prostate cancer	3.31e-05	0.000172	CcSEcCtD
Anastrozole—Ill-defined disorder—Prednisone—prostate cancer	3.3e-05	0.000172	CcSEcCtD
Anastrozole—Rash—Estradiol—prostate cancer	3.29e-05	0.000171	CcSEcCtD
Anastrozole—Dermatitis—Estradiol—prostate cancer	3.29e-05	0.000171	CcSEcCtD
Anastrozole—Anaemia—Prednisone—prostate cancer	3.29e-05	0.000171	CcSEcCtD
Anastrozole—Confusional state—Capecitabine—prostate cancer	3.28e-05	0.000171	CcSEcCtD
Anastrozole—Headache—Estradiol—prostate cancer	3.27e-05	0.00017	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.26e-05	0.00017	CcSEcCtD
Anastrozole—Oedema—Capecitabine—prostate cancer	3.26e-05	0.000169	CcSEcCtD
Anastrozole—Angioedema—Prednisone—prostate cancer	3.25e-05	0.000169	CcSEcCtD
Anastrozole—Infection—Capecitabine—prostate cancer	3.24e-05	0.000168	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—prostate cancer	3.23e-05	0.000168	CcSEcCtD
Anastrozole—Urticaria—Etoposide—prostate cancer	3.22e-05	0.000167	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—prostate cancer	3.21e-05	0.000167	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—prostate cancer	3.21e-05	0.000167	CcSEcCtD
Anastrozole—Anorexia—Docetaxel—prostate cancer	3.21e-05	0.000167	CcSEcCtD
Anastrozole—Malaise—Prednisone—prostate cancer	3.21e-05	0.000167	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—prostate cancer	3.2e-05	0.000167	CcSEcCtD
Anastrozole—Abdominal pain—Etoposide—prostate cancer	3.2e-05	0.000166	CcSEcCtD
Anastrozole—Body temperature increased—Etoposide—prostate cancer	3.2e-05	0.000166	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—prostate cancer	3.2e-05	0.000166	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—prostate cancer	3.19e-05	0.000166	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—prostate cancer	3.19e-05	0.000166	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—prostate cancer	3.17e-05	0.000165	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—prostate cancer	3.16e-05	0.000164	CcSEcCtD
Anastrozole—Hyperhidrosis—Capecitabine—prostate cancer	3.15e-05	0.000164	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—prostate cancer	3.15e-05	0.000164	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—prostate cancer	3.11e-05	0.000162	CcSEcCtD
Anastrozole—Anorexia—Capecitabine—prostate cancer	3.1e-05	0.000162	CcSEcCtD
Anastrozole—Nausea—Estradiol—prostate cancer	3.1e-05	0.000161	CcSEcCtD
Anastrozole—Vomiting—Mitoxantrone—prostate cancer	3.09e-05	0.000161	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—prostate cancer	3.09e-05	0.000161	CcSEcCtD
Anastrozole—Hypertension—Prednisone—prostate cancer	3.07e-05	0.00016	CcSEcCtD
Anastrozole—Rash—Mitoxantrone—prostate cancer	3.07e-05	0.00016	CcSEcCtD
Anastrozole—Dermatitis—Mitoxantrone—prostate cancer	3.07e-05	0.000159	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.06e-05	0.000159	CcSEcCtD
Anastrozole—Headache—Mitoxantrone—prostate cancer	3.05e-05	0.000159	CcSEcCtD
Anastrozole—Insomnia—Docetaxel—prostate cancer	3.04e-05	0.000158	CcSEcCtD
Anastrozole—Myalgia—Prednisone—prostate cancer	3.03e-05	0.000157	CcSEcCtD
Anastrozole—Arthralgia—Prednisone—prostate cancer	3.03e-05	0.000157	CcSEcCtD
Anastrozole—Paraesthesia—Docetaxel—prostate cancer	3.02e-05	0.000157	CcSEcCtD
Anastrozole—Erythema multiforme—Epirubicin—prostate cancer	3.02e-05	0.000157	CcSEcCtD
Anastrozole—Anxiety—Prednisone—prostate cancer	3.02e-05	0.000157	CcSEcCtD
Anastrozole—Dyspnoea—Docetaxel—prostate cancer	3e-05	0.000156	CcSEcCtD
Anastrozole—Somnolence—Docetaxel—prostate cancer	2.99e-05	0.000156	CcSEcCtD
Anastrozole—Discomfort—Prednisone—prostate cancer	2.99e-05	0.000156	CcSEcCtD
Anastrozole—Hypersensitivity—Etoposide—prostate cancer	2.98e-05	0.000155	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—prostate cancer	2.97e-05	0.000155	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.97e-05	0.000154	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—prostate cancer	2.96e-05	0.000154	CcSEcCtD
Anastrozole—Dyspepsia—Docetaxel—prostate cancer	2.96e-05	0.000154	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—prostate cancer	2.95e-05	0.000154	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—prostate cancer	2.95e-05	0.000154	CcSEcCtD
Anastrozole—Insomnia—Capecitabine—prostate cancer	2.95e-05	0.000153	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—prostate cancer	2.93e-05	0.000153	CcSEcCtD
Anastrozole—Paraesthesia—Capecitabine—prostate cancer	2.92e-05	0.000152	CcSEcCtD
Anastrozole—Decreased appetite—Docetaxel—prostate cancer	2.92e-05	0.000152	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—prostate cancer	2.91e-05	0.000151	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Docetaxel—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Asthenia—Etoposide—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Dyspnoea—Capecitabine—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Oedema—Prednisone—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Anaphylactic shock—Prednisone—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Fatigue—Docetaxel—prostate cancer	2.9e-05	0.000151	CcSEcCtD
Anastrozole—Nausea—Mitoxantrone—prostate cancer	2.89e-05	0.00015	CcSEcCtD
Anastrozole—Infection—Prednisone—prostate cancer	2.88e-05	0.00015	CcSEcCtD
Anastrozole—Constipation—Docetaxel—prostate cancer	2.88e-05	0.00015	CcSEcCtD
Anastrozole—Pain—Docetaxel—prostate cancer	2.88e-05	0.00015	CcSEcCtD
Anastrozole—Dyspepsia—Capecitabine—prostate cancer	2.87e-05	0.000149	CcSEcCtD
Anastrozole—Pruritus—Etoposide—prostate cancer	2.86e-05	0.000149	CcSEcCtD
Anastrozole—Decreased appetite—Capecitabine—prostate cancer	2.83e-05	0.000147	CcSEcCtD
Anastrozole—Alopecia—Epirubicin—prostate cancer	2.82e-05	0.000147	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Capecitabine—prostate cancer	2.81e-05	0.000146	CcSEcCtD
Anastrozole—Fatigue—Capecitabine—prostate cancer	2.81e-05	0.000146	CcSEcCtD
Anastrozole—Hyperhidrosis—Prednisone—prostate cancer	2.8e-05	0.000146	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—prostate cancer	2.79e-05	0.000145	CcSEcCtD
Anastrozole—Constipation—Capecitabine—prostate cancer	2.78e-05	0.000145	CcSEcCtD
Anastrozole—Pain—Capecitabine—prostate cancer	2.78e-05	0.000145	CcSEcCtD
Anastrozole—Erythema—Epirubicin—prostate cancer	2.78e-05	0.000145	CcSEcCtD
Anastrozole—Feeling abnormal—Docetaxel—prostate cancer	2.77e-05	0.000144	CcSEcCtD
Anastrozole—Diarrhoea—Etoposide—prostate cancer	2.77e-05	0.000144	CcSEcCtD
Anastrozole—Anorexia—Prednisone—prostate cancer	2.77e-05	0.000144	CcSEcCtD
Anastrozole—Gastrointestinal pain—Docetaxel—prostate cancer	2.75e-05	0.000143	CcSEcCtD
Anastrozole—Tension—Epirubicin—prostate cancer	2.73e-05	0.000142	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—prostate cancer	2.72e-05	0.000142	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—prostate cancer	2.7e-05	0.00014	CcSEcCtD
Anastrozole—Back pain—Epirubicin—prostate cancer	2.69e-05	0.00014	CcSEcCtD
Anastrozole—Feeling abnormal—Capecitabine—prostate cancer	2.68e-05	0.00014	CcSEcCtD
Anastrozole—Dizziness—Etoposide—prostate cancer	2.68e-05	0.000139	CcSEcCtD
Anastrozole—Gastrointestinal pain—Capecitabine—prostate cancer	2.66e-05	0.000139	CcSEcCtD
Anastrozole—Body temperature increased—Docetaxel—prostate cancer	2.66e-05	0.000138	CcSEcCtD
Anastrozole—Abdominal pain—Docetaxel—prostate cancer	2.66e-05	0.000138	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Prednisone—prostate cancer	2.64e-05	0.000138	CcSEcCtD
Anastrozole—Insomnia—Prednisone—prostate cancer	2.62e-05	0.000137	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—prostate cancer	2.61e-05	0.000136	CcSEcCtD
Anastrozole—Paraesthesia—Prednisone—prostate cancer	2.6e-05	0.000136	CcSEcCtD
Anastrozole—Urticaria—Capecitabine—prostate cancer	2.59e-05	0.000135	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—prostate cancer	2.58e-05	0.000134	CcSEcCtD
Anastrozole—Abdominal pain—Capecitabine—prostate cancer	2.57e-05	0.000134	CcSEcCtD
Anastrozole—Body temperature increased—Capecitabine—prostate cancer	2.57e-05	0.000134	CcSEcCtD
Anastrozole—Vomiting—Etoposide—prostate cancer	2.57e-05	0.000134	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—prostate cancer	2.57e-05	0.000134	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—prostate cancer	2.57e-05	0.000134	CcSEcCtD
Anastrozole—Dyspepsia—Prednisone—prostate cancer	2.55e-05	0.000133	CcSEcCtD
Anastrozole—Rash—Etoposide—prostate cancer	2.55e-05	0.000133	CcSEcCtD
Anastrozole—Dermatitis—Etoposide—prostate cancer	2.55e-05	0.000133	CcSEcCtD
Anastrozole—Headache—Etoposide—prostate cancer	2.54e-05	0.000132	CcSEcCtD
Anastrozole—Tension—Doxorubicin—prostate cancer	2.52e-05	0.000131	CcSEcCtD
Anastrozole—Decreased appetite—Prednisone—prostate cancer	2.52e-05	0.000131	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—prostate cancer	2.52e-05	0.000131	CcSEcCtD
Anastrozole—Malaise—Epirubicin—prostate cancer	2.51e-05	0.00013	CcSEcCtD
Anastrozole—Fatigue—Prednisone—prostate cancer	2.5e-05	0.00013	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—prostate cancer	2.5e-05	0.00013	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—prostate cancer	2.49e-05	0.000129	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—prostate cancer	2.49e-05	0.000129	CcSEcCtD
Anastrozole—Constipation—Prednisone—prostate cancer	2.48e-05	0.000129	CcSEcCtD
Anastrozole—Hypersensitivity—Docetaxel—prostate cancer	2.48e-05	0.000129	CcSEcCtD
Anastrozole—Cough—Epirubicin—prostate cancer	2.43e-05	0.000126	CcSEcCtD
Anastrozole—Asthenia—Docetaxel—prostate cancer	2.41e-05	0.000126	CcSEcCtD
Anastrozole—Nausea—Etoposide—prostate cancer	2.4e-05	0.000125	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—prostate cancer	2.4e-05	0.000125	CcSEcCtD
Anastrozole—Hypersensitivity—Capecitabine—prostate cancer	2.4e-05	0.000125	CcSEcCtD
Anastrozole—Feeling abnormal—Prednisone—prostate cancer	2.39e-05	0.000124	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—prostate cancer	2.39e-05	0.000124	CcSEcCtD
Anastrozole—Pruritus—Docetaxel—prostate cancer	2.38e-05	0.000124	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—prostate cancer	2.38e-05	0.000124	CcSEcCtD
Anastrozole—Gastrointestinal pain—Prednisone—prostate cancer	2.37e-05	0.000123	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—prostate cancer	2.37e-05	0.000123	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—prostate cancer	2.37e-05	0.000123	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—prostate cancer	2.37e-05	0.000123	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—prostate cancer	2.36e-05	0.000123	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—prostate cancer	2.34e-05	0.000122	CcSEcCtD
Anastrozole—Asthenia—Capecitabine—prostate cancer	2.34e-05	0.000122	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—prostate cancer	2.32e-05	0.000121	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—prostate cancer	2.31e-05	0.00012	CcSEcCtD
Anastrozole—Urticaria—Prednisone—prostate cancer	2.3e-05	0.00012	CcSEcCtD
Anastrozole—Pruritus—Capecitabine—prostate cancer	2.3e-05	0.00012	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—prostate cancer	2.3e-05	0.00012	CcSEcCtD
Anastrozole—Diarrhoea—Docetaxel—prostate cancer	2.3e-05	0.00012	CcSEcCtD
Anastrozole—Body temperature increased—Prednisone—prostate cancer	2.29e-05	0.000119	CcSEcCtD
Anastrozole—Abdominal pain—Prednisone—prostate cancer	2.29e-05	0.000119	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—prostate cancer	2.29e-05	0.000119	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—prostate cancer	2.27e-05	0.000118	CcSEcCtD
Anastrozole—Oedema—Epirubicin—prostate cancer	2.27e-05	0.000118	CcSEcCtD
Anastrozole—Infection—Epirubicin—prostate cancer	2.25e-05	0.000117	CcSEcCtD
Anastrozole—Cough—Doxorubicin—prostate cancer	2.24e-05	0.000117	CcSEcCtD
Anastrozole—Diarrhoea—Capecitabine—prostate cancer	2.23e-05	0.000116	CcSEcCtD
Anastrozole—Dizziness—Docetaxel—prostate cancer	2.22e-05	0.000116	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—prostate cancer	2.22e-05	0.000116	CcSEcCtD
Anastrozole—Hyperhidrosis—Epirubicin—prostate cancer	2.19e-05	0.000114	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—prostate cancer	2.19e-05	0.000114	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—prostate cancer	2.19e-05	0.000114	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—prostate cancer	2.19e-05	0.000114	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—prostate cancer	2.18e-05	0.000114	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—prostate cancer	2.16e-05	0.000113	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—prostate cancer	2.16e-05	0.000113	CcSEcCtD
Anastrozole—Dizziness—Capecitabine—prostate cancer	2.15e-05	0.000112	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—prostate cancer	2.14e-05	0.000111	CcSEcCtD
Anastrozole—Vomiting—Docetaxel—prostate cancer	2.14e-05	0.000111	CcSEcCtD
Anastrozole—Hypersensitivity—Prednisone—prostate cancer	2.14e-05	0.000111	CcSEcCtD
Anastrozole—Rash—Docetaxel—prostate cancer	2.12e-05	0.00011	CcSEcCtD
Anastrozole—Dermatitis—Docetaxel—prostate cancer	2.12e-05	0.00011	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—prostate cancer	2.12e-05	0.00011	CcSEcCtD
Anastrozole—Headache—Docetaxel—prostate cancer	2.11e-05	0.00011	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—prostate cancer	2.1e-05	0.000109	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—prostate cancer	2.1e-05	0.000109	CcSEcCtD
Anastrozole—Infection—Doxorubicin—prostate cancer	2.09e-05	0.000109	CcSEcCtD
Anastrozole—Asthenia—Prednisone—prostate cancer	2.08e-05	0.000108	CcSEcCtD
Anastrozole—Vomiting—Capecitabine—prostate cancer	2.07e-05	0.000108	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.07e-05	0.000108	CcSEcCtD
Anastrozole—Rash—Capecitabine—prostate cancer	2.05e-05	0.000107	CcSEcCtD
Anastrozole—Pruritus—Prednisone—prostate cancer	2.05e-05	0.000107	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—prostate cancer	2.05e-05	0.000107	CcSEcCtD
Anastrozole—Dermatitis—Capecitabine—prostate cancer	2.05e-05	0.000107	CcSEcCtD
Anastrozole—Headache—Capecitabine—prostate cancer	2.04e-05	0.000106	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—prostate cancer	2.04e-05	0.000106	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—prostate cancer	2.03e-05	0.000106	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—prostate cancer	2.02e-05	0.000105	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—prostate cancer	2.02e-05	0.000105	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—prostate cancer	2e-05	0.000104	CcSEcCtD
Anastrozole—Nausea—Docetaxel—prostate cancer	2e-05	0.000104	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—prostate cancer	2e-05	0.000104	CcSEcCtD
Anastrozole—Diarrhoea—Prednisone—prostate cancer	1.98e-05	0.000103	CcSEcCtD
Anastrozole—Decreased appetite—Epirubicin—prostate cancer	1.97e-05	0.000103	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—prostate cancer	1.96e-05	0.000102	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—prostate cancer	1.96e-05	0.000102	CcSEcCtD
Anastrozole—Constipation—Epirubicin—prostate cancer	1.94e-05	0.000101	CcSEcCtD
Anastrozole—Pain—Epirubicin—prostate cancer	1.94e-05	0.000101	CcSEcCtD
Anastrozole—Nausea—Capecitabine—prostate cancer	1.93e-05	0.000101	CcSEcCtD
Anastrozole—Dizziness—Prednisone—prostate cancer	1.92e-05	9.98e-05	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.91e-05	9.95e-05	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—prostate cancer	1.9e-05	9.88e-05	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—prostate cancer	1.88e-05	9.81e-05	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—prostate cancer	1.87e-05	9.74e-05	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—prostate cancer	1.87e-05	9.73e-05	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—prostate cancer	1.87e-05	9.71e-05	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—prostate cancer	1.86e-05	9.65e-05	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—prostate cancer	1.85e-05	9.61e-05	CcSEcCtD
Anastrozole—Vomiting—Prednisone—prostate cancer	1.84e-05	9.6e-05	CcSEcCtD
Anastrozole—Rash—Prednisone—prostate cancer	1.83e-05	9.52e-05	CcSEcCtD
Anastrozole—Dermatitis—Prednisone—prostate cancer	1.83e-05	9.51e-05	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—prostate cancer	1.82e-05	9.5e-05	CcSEcCtD
Anastrozole—Headache—Prednisone—prostate cancer	1.82e-05	9.46e-05	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.81e-05	9.43e-05	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—prostate cancer	1.81e-05	9.42e-05	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—prostate cancer	1.8e-05	9.38e-05	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—prostate cancer	1.8e-05	9.34e-05	CcSEcCtD
Anastrozole—Pain—Doxorubicin—prostate cancer	1.8e-05	9.34e-05	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—prostate cancer	1.79e-05	9.33e-05	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—prostate cancer	1.79e-05	9.33e-05	CcSEcCtD
Anastrozole—Feeling abnormal—Doxorubicin—prostate cancer	1.73e-05	9e-05	CcSEcCtD
Anastrozole—Nausea—Prednisone—prostate cancer	1.72e-05	8.97e-05	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—prostate cancer	1.72e-05	8.93e-05	CcSEcCtD
Anastrozole—Hypersensitivity—Epirubicin—prostate cancer	1.67e-05	8.7e-05	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—prostate cancer	1.67e-05	8.68e-05	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—prostate cancer	1.66e-05	8.63e-05	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—prostate cancer	1.66e-05	8.63e-05	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—prostate cancer	1.63e-05	8.47e-05	CcSEcCtD
Anastrozole—Pruritus—Epirubicin—prostate cancer	1.61e-05	8.35e-05	CcSEcCtD
Anastrozole—Diarrhoea—Epirubicin—prostate cancer	1.55e-05	8.08e-05	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—prostate cancer	1.55e-05	8.05e-05	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—prostate cancer	1.51e-05	7.84e-05	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—prostate cancer	1.5e-05	7.81e-05	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—prostate cancer	1.49e-05	7.73e-05	CcSEcCtD
Anastrozole—Vomiting—Epirubicin—prostate cancer	1.44e-05	7.51e-05	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—prostate cancer	1.44e-05	7.47e-05	CcSEcCtD
Anastrozole—Rash—Epirubicin—prostate cancer	1.43e-05	7.44e-05	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—prostate cancer	1.43e-05	7.44e-05	CcSEcCtD
Anastrozole—Headache—Epirubicin—prostate cancer	1.42e-05	7.4e-05	CcSEcCtD
Anastrozole—Dizziness—Doxorubicin—prostate cancer	1.39e-05	7.22e-05	CcSEcCtD
Anastrozole—Nausea—Epirubicin—prostate cancer	1.35e-05	7.01e-05	CcSEcCtD
Anastrozole—Vomiting—Doxorubicin—prostate cancer	1.33e-05	6.94e-05	CcSEcCtD
Anastrozole—Rash—Doxorubicin—prostate cancer	1.32e-05	6.89e-05	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—prostate cancer	1.32e-05	6.88e-05	CcSEcCtD
Anastrozole—Headache—Doxorubicin—prostate cancer	1.32e-05	6.84e-05	CcSEcCtD
Anastrozole—Nausea—Doxorubicin—prostate cancer	1.25e-05	6.49e-05	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—LPL—prostate cancer	7.44e-06	8.51e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.39e-06	8.45e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—UMPS—prostate cancer	7.34e-06	8.4e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PHGDH—prostate cancer	7.34e-06	8.4e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ARG2—prostate cancer	7.34e-06	8.4e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	7.3e-06	8.35e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA4—prostate cancer	7.3e-06	8.35e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TBXAS1—prostate cancer	7.3e-06	8.35e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—LDHB—prostate cancer	7.2e-06	8.23e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A1—prostate cancer	7.18e-06	8.22e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.14e-06	8.16e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ERCC2—prostate cancer	7.12e-06	8.15e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA2—prostate cancer	7.11e-06	8.14e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP3A5—prostate cancer	7.06e-06	8.08e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ABCG5—prostate cancer	7.03e-06	8.04e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SULT1A1—prostate cancer	7.03e-06	8.04e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HPGD—prostate cancer	6.95e-06	7.95e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.95e-06	7.95e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTA1—prostate cancer	6.86e-06	7.85e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA3—prostate cancer	6.82e-06	7.8e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—UCP3—prostate cancer	6.82e-06	7.8e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PDHA1—prostate cancer	6.82e-06	7.8e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TCN2—prostate cancer	6.82e-06	7.8e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTO1—prostate cancer	6.79e-06	7.77e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HSD3B2—prostate cancer	6.79e-06	7.77e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NAT2—prostate cancer	6.79e-06	7.77e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—MTHFR—prostate cancer	6.69e-06	7.66e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPARA—prostate cancer	6.57e-06	7.52e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.53e-06	7.47e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.53e-06	7.47e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC22A3—prostate cancer	6.51e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HSD3B1—prostate cancer	6.51e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—LRP2—prostate cancer	6.51e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PLCB2—prostate cancer	6.51e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2C18—prostate cancer	6.51e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—P4HB—prostate cancer	6.38e-06	7.3e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP7B1—prostate cancer	6.35e-06	7.27e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—MTAP—prostate cancer	6.35e-06	7.27e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.31e-06	7.22e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TBXAS1—prostate cancer	6.24e-06	7.14e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA4—prostate cancer	6.24e-06	7.14e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC22A1—prostate cancer	6.21e-06	7.1e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SULT1E1—prostate cancer	6.19e-06	7.08e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SRD5A1—prostate cancer	6.19e-06	7.08e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CAV1—prostate cancer	6.18e-06	7.07e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.14e-06	7.02e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.1e-06	6.98e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA2—prostate cancer	6.08e-06	6.96e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SULT2A1—prostate cancer	6.05e-06	6.92e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ABCG5—prostate cancer	6.01e-06	6.87e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SULT1A1—prostate cancer	6.01e-06	6.87e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—MED12—prostate cancer	5.95e-06	6.81e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.91e-06	6.76e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ACSL4—prostate cancer	5.91e-06	6.76e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GNG5—prostate cancer	5.9e-06	6.76e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.9e-06	6.75e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTA1—prostate cancer	5.87e-06	6.71e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HSD3B2—prostate cancer	5.8e-06	6.64e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NAT2—prostate cancer	5.8e-06	6.64e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTO1—prostate cancer	5.8e-06	6.64e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NCOA3—prostate cancer	5.69e-06	6.51e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ARG2—prostate cancer	5.66e-06	6.48e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—UMPS—prostate cancer	5.66e-06	6.48e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PHGDH—prostate cancer	5.66e-06	6.48e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CG—prostate cancer	5.62e-06	6.44e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.59e-06	6.4e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.58e-06	6.38e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—LRP2—prostate cancer	5.56e-06	6.36e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PLCB2—prostate cancer	5.56e-06	6.36e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2C18—prostate cancer	5.56e-06	6.36e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—LDHB—prostate cancer	5.55e-06	6.35e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—P4HB—prostate cancer	5.45e-06	6.24e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.45e-06	6.24e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HPGDS—prostate cancer	5.43e-06	6.21e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2C19—prostate cancer	5.39e-06	6.17e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—INS—prostate cancer	5.32e-06	6.09e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC22A1—prostate cancer	5.3e-06	6.07e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PDHA1—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA3—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TCN2—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—UCP3—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTT1—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ACHE—prostate cancer	5.26e-06	6.02e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.24e-06	6e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CREBBP—prostate cancer	5.22e-06	5.97e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2A6—prostate cancer	5.2e-06	5.95e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.18e-06	5.93e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SULT2A1—prostate cancer	5.17e-06	5.92e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—MED12—prostate cancer	5.09e-06	5.82e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKR1C3—prostate cancer	5.06e-06	5.79e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GNG5—prostate cancer	5.05e-06	5.77e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PRKACB—prostate cancer	5.03e-06	5.76e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.02e-06	5.75e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.02e-06	5.75e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.98e-06	5.7e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CD—prostate cancer	4.94e-06	5.66e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.91e-06	5.62e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NCOA3—prostate cancer	4.86e-06	5.56e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.81e-06	5.51e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA4—prostate cancer	4.81e-06	5.51e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.78e-06	5.46e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NCOA2—prostate cancer	4.75e-06	5.43e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA2—prostate cancer	4.69e-06	5.37e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NOS3—prostate cancer	4.67e-06	5.34e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HPGDS—prostate cancer	4.64e-06	5.31e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.63e-06	5.3e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ABCG5—prostate cancer	4.63e-06	5.3e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2C19—prostate cancer	4.61e-06	5.27e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC5A5—prostate cancer	4.53e-06	5.18e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTA1—prostate cancer	4.53e-06	5.18e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTT1—prostate cancer	4.5e-06	5.15e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ACHE—prostate cancer	4.5e-06	5.15e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.48e-06	5.12e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTO1—prostate cancer	4.48e-06	5.12e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NAT2—prostate cancer	4.48e-06	5.12e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.45e-06	5.09e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.43e-06	5.07e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.42e-06	5.06e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NQO1—prostate cancer	4.37e-06	5e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.32e-06	4.95e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TH—prostate cancer	4.31e-06	4.93e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CB—prostate cancer	4.31e-06	4.93e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PRKACB—prostate cancer	4.3e-06	4.92e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PLCB2—prostate cancer	4.29e-06	4.91e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.29e-06	4.91e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—LRP2—prostate cancer	4.29e-06	4.91e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.28e-06	4.9e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—prostate cancer	4.27e-06	4.89e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.26e-06	4.88e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.26e-06	4.87e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.24e-06	4.86e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—P4HB—prostate cancer	4.21e-06	4.82e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.2e-06	4.8e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.19e-06	4.8e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.09e-06	4.68e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GGT1—prostate cancer	4.06e-06	4.65e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NCOA2—prostate cancer	4.06e-06	4.64e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NCOA1—prostate cancer	4e-06	4.58e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.99e-06	4.57e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.94e-06	4.51e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—MED12—prostate cancer	3.92e-06	4.49e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GNG5—prostate cancer	3.89e-06	4.46e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.87e-06	4.43e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—RXRA—prostate cancer	3.8e-06	4.35e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.78e-06	4.32e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NCOA3—prostate cancer	3.75e-06	4.29e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NQO1—prostate cancer	3.74e-06	4.28e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—prostate cancer	3.72e-06	4.26e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.7e-06	4.23e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TH—prostate cancer	3.68e-06	4.21e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—COMT—prostate cancer	3.66e-06	4.19e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.66e-06	4.19e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—prostate cancer	3.65e-06	4.17e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.64e-06	4.17e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.63e-06	4.15e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ITPR1—prostate cancer	3.59e-06	4.11e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.58e-06	4.1e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HPGDS—prostate cancer	3.58e-06	4.09e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.56e-06	4.07e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—EP300—prostate cancer	3.55e-06	4.06e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.53e-06	4.04e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTT1—prostate cancer	3.47e-06	3.97e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ACHE—prostate cancer	3.47e-06	3.97e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GGT1—prostate cancer	3.47e-06	3.97e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.43e-06	3.93e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NCOA1—prostate cancer	3.42e-06	3.91e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TYMS—prostate cancer	3.39e-06	3.88e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.37e-06	3.85e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTM1—prostate cancer	3.35e-06	3.84e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.34e-06	3.82e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PRKACB—prostate cancer	3.32e-06	3.8e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—LPL—prostate cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.29e-06	3.76e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—RXRA—prostate cancer	3.25e-06	3.72e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.18e-06	3.64e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.16e-06	3.62e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ERCC2—prostate cancer	3.15e-06	3.61e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—COMT—prostate cancer	3.13e-06	3.58e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NCOA2—prostate cancer	3.13e-06	3.58e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—prostate cancer	3.12e-06	3.57e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ITPR1—prostate cancer	3.07e-06	3.51e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.02e-06	3.45e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.99e-06	3.42e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—MTHFR—prostate cancer	2.96e-06	3.39e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPARA—prostate cancer	2.91e-06	3.33e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TYMS—prostate cancer	2.9e-06	3.32e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NQO1—prostate cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTM1—prostate cancer	2.86e-06	3.28e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TH—prostate cancer	2.84e-06	3.25e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—LPL—prostate cancer	2.81e-06	3.22e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.77e-06	3.16e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CAV1—prostate cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ERCC2—prostate cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GGT1—prostate cancer	2.68e-06	3.06e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NCOA1—prostate cancer	2.64e-06	3.02e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—prostate cancer	2.63e-06	3.01e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.61e-06	2.99e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.6e-06	2.97e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—MTHFR—prostate cancer	2.53e-06	2.9e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—RXRA—prostate cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPARA—prostate cancer	2.48e-06	2.84e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—COMT—prostate cancer	2.42e-06	2.77e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—prostate cancer	2.41e-06	2.75e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ITPR1—prostate cancer	2.37e-06	2.71e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—INS—prostate cancer	2.36e-06	2.7e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CAV1—prostate cancer	2.34e-06	2.67e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CREBBP—prostate cancer	2.31e-06	2.64e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TYMS—prostate cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.23e-06	2.55e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTM1—prostate cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.19e-06	2.5e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—LPL—prostate cancer	2.17e-06	2.48e-05	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—prostate cancer	2.15e-06	2.46e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.13e-06	2.43e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.1e-06	2.4e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ERCC2—prostate cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NOS3—prostate cancer	2.07e-06	2.36e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—INS—prostate cancer	2.01e-06	2.3e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CREBBP—prostate cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—MTHFR—prostate cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPARA—prostate cancer	1.92e-06	2.19e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.91e-06	2.18e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—prostate cancer	1.89e-06	2.16e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CAV1—prostate cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NOS3—prostate cancer	1.77e-06	2.02e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—prostate cancer	1.65e-06	1.89e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.64e-06	1.88e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.63e-06	1.86e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—prostate cancer	1.61e-06	1.85e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—EP300—prostate cancer	1.57e-06	1.8e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—INS—prostate cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CREBBP—prostate cancer	1.52e-06	1.74e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—prostate cancer	1.41e-06	1.61e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NOS3—prostate cancer	1.36e-06	1.56e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—EP300—prostate cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.25e-06	1.43e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.16e-06	1.33e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—prostate cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—EP300—prostate cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—prostate cancer	9.94e-07	1.14e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—prostate cancer	9.5e-07	1.09e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—prostate cancer	8.12e-07	9.29e-06	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.67e-07	8.77e-06	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—prostate cancer	6.26e-07	7.17e-06	CbGpPWpGaD
